Literature DB >> 18644012

A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation.

A Wald1, C Scarpignato, S Mueller-Lissner, M A Kamm, U Hinkel, I Helfrich, C Schuijt, K G Mandel.   

Abstract

BACKGROUND: While numerous studies report prevalence of constipation, use of laxatives is poorly understood. AIM: To conduct a survey in seven countries evaluating prevalence of constipation and laxative use in its treatment.
METHODS: Thirteen thousand eight hundred seventy-nine adults [approximately 2000 each from US, UK, Germany (GE), France (FR), Italy (IT), Brazil (BR) and South Korea (SK)] completed questionnaires assessing occurrence, frequency, duration and laxative use for treating constipation.
RESULTS: Overall, 12.3% of adults had constipation [range: 5% (GE) to 18% (US)] in the prior year. A greater percent of women from all countries and elderly from all except SK and BR reported constipation; odds ratios for constipation among women and elderly were 2.43 (95% CI: 2.18-2.71) and 1.5 (95% CI: 1.25-1.73) vs. men and young subjects. Among those with constipation, 16% (SK) to 40% (US) used laxatives. Laxative use was generally associated with increasing age, symptom frequency and lower income and education. A similar percentage of men and women with constipation reported using laxatives; a greater percentage of women used laxatives for a longer time.
CONCLUSIONS: Prevalence of self-defined constipation and laxative use varies among countries. Prevalence is generally related to gender and age, whereas laxative use is related to age, but not to gender.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18644012     DOI: 10.1111/j.1365-2036.2008.03806.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  68 in total

1.  Chronic constipation, more needs to be done.

Authors:  Kok-Ann Gwee
Journal:  Indian J Gastroenterol       Date:  2018-11

2.  Laxative type in relation to colorectal cancer risk.

Authors:  Jessica S Citronberg; Sheetal Hardikar; Amanda Phipps; Jane C Figueiredo; Polly Newcomb
Journal:  Ann Epidemiol       Date:  2018-07-09       Impact factor: 3.797

Review 3.  American Gastroenterological Association technical review on constipation.

Authors:  Adil E Bharucha; John H Pemberton; G Richard Locke
Journal:  Gastroenterology       Date:  2013-01       Impact factor: 22.682

4.  Prevalence of constipation in the German population - a representative survey (GECCO).

Authors:  Paul Enck; Johannes Leinert; Menno Smid; Thorsten Köhler; Juliane Schwille-Kiuntke
Journal:  United European Gastroenterol J       Date:  2015-08-21       Impact factor: 4.623

Review 5.  An update on prucalopride in the treatment of chronic constipation.

Authors:  Anam Omer; Eamonn M M Quigley
Journal:  Therap Adv Gastroenterol       Date:  2017-10-16       Impact factor: 4.409

6.  Clinical factors associated with constipation in hemodialysis patients.

Authors:  Ryota Ikee; Takayuki Toyoyama; Toko Endo; Masataka Tsunoda; Nobuo Hashimoto
Journal:  Int Urol Nephrol       Date:  2016-07-05       Impact factor: 2.370

7.  Physiologic Management of Chronic Constipation: Let's FEED It.

Authors:  Pankaj Garg
Journal:  Dig Dis Sci       Date:  2017-09-25       Impact factor: 3.199

Review 8.  Chronic constipation: current treatment options.

Authors:  Louis Wing Cheong Liu
Journal:  Can J Gastroenterol       Date:  2011-10       Impact factor: 3.522

Review 9.  Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.

Authors:  Khaled A Jadallah; Susan M Kullab; David S Sanders
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

10.  Percutaneous endoscopic caecostomy for severe constipation in adults: feasibility, durability, functional and quality of life results at 1 year follow-up.

Authors:  Emilie Duchalais; Guillaume Meurette; Surendra K Mantoo; Marc Le Rhun; Stanislas Bruley des Varannes; Paul-Antoine Lehur; Emmanuel Coron
Journal:  Surg Endosc       Date:  2014-07-17       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.